• BPN-19186 for sEH–Nrf2 Assays

  2026-08-21

  BPN-19186 offers a practical chemical-perturbation route for testing the sEH–Nrf2 connection in osteoclastogenesis and redox assays. This workflow combines enzyme screening, lipid-metabolite measurements, cell differentiation, and orthogonal pathway readouts while emphasizing solubility control and careful interpretation.

• ddATP as a Probe of Replication-Linked DNA Damage

  2026-08-20

  ddATP is more than a sequencing reagent: its defined chain-termination chemistry can help translational researchers interrogate polymerase-dependent DNA synthesis. Evidence from mouse oocytes connects ddATP-sensitive synthesis with short-scale break-induced replication and damage amplification, while highlighting the controls needed to avoid overinterpreting inhibitor-based results.

• NF-κB–miR-202-5p–HMGB2 in Septic AKI

  2026-08-20

  The reference study identifies an adaptive NF-κB/miR-202-5p/HMGB2 feedback loop that limits renal inflammation and tubular cell death during sepsis-associated acute kidney injury. Its combined cellular, molecular, and in vivo evidence positions miR-202-5p as a potential brake on HMGB2-supported NF-κB signaling, while also highlighting important requirements for validating pathway-directed interventions.

• Ziprasidone HCl for Caco-2 and GOT1 Workflows

  2026-08-19

  Ziprasidone HCl supports two complementary research workflows: formulation-enabled permeability testing and mechanism-focused studies of GOT1-dependent tumor metabolism. This guide connects the reference Caco-2 nanocrystal findings with practical cancer, migration, and receptor-signaling assays while emphasizing formulation, vehicle, and monolayer controls.

• Ginsenoside Rg1: From Phenotype to Causal Assay

  2026-08-19

  Ginsenoside Rg1 is examined here as a causal assay tool rather than only a neuroprotective candidate. Learn how to connect behavioral, synaptic, inflammatory, gut-barrier, and regulatory T-cell readouts while preserving chemical and evidentiary rigor.

• EZ Cap™ Human PTEN mRNA: Evidence & Workflow

  2026-08-18

  EZ Cap™ Human PTEN mRNA is a Cap 1, poly(A)-tailed tumor suppressor gene mRNA for transient human PTEN expression. Its defined 1467-nucleotide format and research-use handling profile support cancer research, pathway studies, and experimental mRNA delivery development.

• Dabigatran etexilate in Thrombin Assay Workflows

  2026-08-18

  Dabigatran etexilate provides a practical tool for linking thrombin biochemistry with plasma coagulation and platelet studies. This workflow-focused guide covers prodrug handling, concentration design, orthogonal readouts, and troubleshooting for anticoagulant research.

• SR-202 Workflows for PPARγ Mechanism Studies

  2026-08-17

  SR-202 provides a selective way to test whether PPARγ activity connects macrophage polarization, adipocyte differentiation, and metabolic phenotypes. This practical guide converts the reference study into cell-based workflows, controls, troubleshooting checkpoints, and translational assay strategies.

• Merbromin Inhibits SARS-CoV-2 3CLpro

  2026-08-17

  A high-throughput study screened approximately 6,000 compounds and identified Merbromin as a selective, mixed-type inhibitor of the SARS-CoV-2 3-chymotrypsin-like protease, 3CLpro. Kinetic, surface-binding, and docking analyses support a multi-site inhibition model, while also defining the compound as an early antiviral screening lead rather than a clinically validated antiviral.

• FAK Inhibitor 14: A Mechanistic Assay Guide

  2026-08-16

  Explore how FAK Inhibitor 14 can clarify the FAK signaling pathway in cancer biology research. This guide connects product handling with causal assay design for cell migration inhibition and tumor metastasis research.

• L-NAME Hydrochloride: From NO Biology to Translation

  2026-08-15

  A mechanistic and strategic guide to using L-NAME Hydrochloride as an orthogonal NOS perturbation tool in vascular tone regulation studies, hypertension research, and inflammation-focused translational models.

• Imipenem Workflows for Resistance Research

  2026-08-14

  Imipenem supports more than routine antibacterial screening: it can connect susceptibility testing with plasmid-transfer surveillance and immune-cell assays. This practical guide translates recent CREC transmission findings into reproducible, research-use-only workflows with troubleshooting strategies for aqueous preparation, phenotype interpretation, and cross-domain validation.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody Workflow

  2026-08-14

  Build sensitive rabbit-primary detection workflows for immunofluorescence, flow cytometry, and fluorescent tissue imaging with a FITC-conjugated secondary. This practical guide connects assay design and troubleshooting to the IL-11 pulmonary fibrosis study while clearly separating validated product specifications from optimization starting points.

• EdU Imaging Kits (Cy3) for HCC S-Phase Studies

  2026-08-13

  EdU Imaging Kits (Cy3) provide a non-denaturing way to connect S-phase DNA synthesis with the NPC1/USP7/p53 biology of hepatocellular carcinoma. This article translates the reference study into practical imaging and flow-cytometry decisions while clarifying what an EdU endpoint can—and cannot—prove.

• Perospirone Inhibits Coronary Kv Channels

  2026-08-13

  The reference study identifies a previously unrecognized vascular ion-channel action of perospirone: concentration-dependent inhibition of Kv currents in freshly isolated rabbit coronary arterial smooth muscle cells. Its electrophysiological and pharmacological analyses implicate Kv1.5 channels and provide a mechanistic basis for investigating cardiovascular consequences alongside established serotonergic and dopaminergic effects.

8001 records 2/534 page Previous Next 12345 下5页 Last page